Literature DB >> 32327600

Against pandemic research exceptionalism.

Alex John London1, Jonathan Kimmelman2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32327600     DOI： 10.1126/science.abc1731

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  87 in total

1.  COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.

Authors:  Tiffany Thomas; Davide Stefanoni; Julie A Reisz; Travis Nemkov; Lorenzo Bertolone; Richard O Francis; Krystalyn E Hudson; James C Zimring; Kirk C Hansen; Eldad A Hod; Steven L Spitalnik; Angelo D'Alessandro
Journal:  JCI Insight       Date:  2020-07-23

2.  Realizing Present and Future Promise of DIY Biology and Medicine through a Trust Architecture.

Authors:  Lisa M Rasmussen; Christi J Guerrini; Todd Kuiken; Camille Nebeker; Alex Pearlman; Sarah B Ware; Anna Wexler; Patricia J Zettler
Journal:  Hastings Cent Rep       Date:  2020-11       Impact factor: 2.683

3.  COVID-19 and cancer: do we really know what we think we know?

Authors:  Andrew G Robinson; Bishal Gyawali; Gerald Evans
Journal:  Nat Rev Clin Oncol       Date:  2020-07       Impact factor: 66.675

4.  Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Authors:  Jeffrey P Kahn; Leslie Meltzer Henry; Anna C Mastroianni; Wilbur H Chen; Ruth Macklin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

5.  Self-experimentation, ethics, and regulation of vaccines.

Authors:  Christi J Guerrini; Jacob S Sherkow; Michelle N Meyer; Patricia J Zettler
Journal:  Science       Date:  2020-09-17       Impact factor: 47.728

6.  An ethics framework for consolidating and prioritizing COVID-19 clinical trials.

Authors:  Michelle N Meyer; Luke Gelinas; Barbara E Bierer; Sara Chandros Hull; Steven Joffe; David Magnus; Seema Mohapatra; Richard R Sharp; Kayte Spector-Bagdady; Jeremy Sugarman; Benjamin S Wilfond; Holly Fernandez Lynch
Journal:  Clin Trials       Date:  2021-02-02       Impact factor: 2.486

7.  Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors:  Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

Review 8.  Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

Authors:  Wen Shi Lee; Adam K Wheatley; Stephen J Kent; Brandon J DeKosky
Journal:  Nat Microbiol       Date:  2020-09-09       Impact factor: 17.745

9.  Aggregating data from COVID-19 trials.

Authors:  Elizabeth L Ogburn; Barbara E Bierer; Ron Brookmeyer; Christine Choirat; Natalie E Dean; Victor De Gruttola; Susan S Ellenberg; M Elizabeth Halloran; Daniel F Hanley; Joseph K Lee; Rui Wang; Daniel O Scharfstein
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

10.  Assessment of COVID-19-related meta-analysis reporting quality.

Authors:  Nosaiba Al-Ryalat; Omar Al-Rashdan; Bayan Alaaraj; Ahmad A Toubasi; Hadil Alsghaireen; Abeer Yaseen; Ahmad Mesmar; Saif Aldeen AlRyalat
Journal:  Ir J Med Sci       Date:  2021-07-06       Impact factor: 1.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.